Magazine article Clinical Psychiatry News

Measure Fasting Glucose in Nondiabetic MI Patients

Magazine article Clinical Psychiatry News

Measure Fasting Glucose in Nondiabetic MI Patients

Article excerpt

NEW ORLEANS -- An elevated fasting glucose in nondiabetic patients with acute myocardial infarction is a powerful predictor of increased 30-day mortality, Dr. Mahmoud Suleiman said at the annual meeting of the American College of Cardiology.

It's well established that diabetic patients have worse outcomes than nondiabetics following MI. But the observation in Dr. Suleiman's new prospective study that even hyperglycemia below the diabetic threshold carries increased risk raises an important question warranting study in a large randomized controlled trial: Will treatment of elevated fasting blood glucose in nondiabetic patients during the acute phase of an MI lead to improved outcomes?

He reported on 577 patients without a history of diabetes whose blood glucose was measured following an 8-hour fast with in 24 hours after admission for an acute MI. The patients were divided into tertiles based upon fasting blood glucose: those with a level below 97 mg/dL, an intermediate group at 97-118 mg/dL, and those with a level above 118 mg/dL. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.